For years, the Texas medical cannabis program existed more on paper than in practice. Strict eligibility rules, limited products, and only a handful of licensed operators left many patients searching elsewhere for relief. Major reforms taking effect in 2026 are expanding patient access and drawing interest from national cannabis companies.
Key Takeaways
- Texas significantly expanded its medical cannabis program through House Bill 46
- Patient eligibility and product options are broader than at any point since 2015
- National cannabis companies are preparing to enter the Texas market
- Physician participation and federal policy shifts may influence long-term growth
How the Texas Medical Cannabis Program Fell Behind
The Texas medical cannabis program, established in 2015 as the Texas Compassionate Use Program, launched with one of the most restrictive frameworks in the country. Only patients with severe epilepsy qualified, only low-THC oil was permitted, and just three vertically integrated companies were licensed to serve the entire state.
For many patients, the program felt inaccessible or impractical. State officials later acknowledged that one licensed operator was effectively nonfunctional for several years. Advocates argued the narrow scope discouraged both doctors and businesses from participating.
As medical access stalled, hemp-derived THC products became widely available. Patients who could not qualify for TCUP, or who could not find a registered physician, increasingly turned to hemp THC sold online and in thousands of storefronts across Texas.
What House Bill 46 Changed for the Texas Medical Cannabis Program
Governor Greg Abbott signed House Bill 46 in June 2025, marking the most substantial expansion of the Texas medical cannabis program since its creation. Final rules released later that year reshaped both patient access and business participation.
Cannabis products may now contain up to 10 milligrams of THC per dose, with a maximum of 1,000 milligrams per package. The number of licensed dispensing organizations increased from three to 15 statewide, easing long-standing access bottlenecks.
The law also expanded qualifying conditions to include chronic pain and terminal illnesses, while granting regulators authority to add future conditions without additional legislation. Patients can now access products such as topicals, patches, suppositories, and prescribed inhalers, though smokable flower remains prohibited.
Patient Enrollment Is Growing, but Texas Still Lags Behind
Enrollment in the Texas medical cannabis program reached 135,470 patients by the end of 2025, representing nearly 32 percent year-over-year growth. Monthly enrollment growth has averaged roughly three percent since 2023, adding about 100,000 patients during that period.
Even so, participation remains low for a state of more than 31 million residents. Fewer than 0.5 percent of Texans are enrolled, compared with a national medical cannabis enrollment average of approximately 2.1 percent, according to a 2024 study funded by the National Institute on Drug Abuse.
Physician participation remains a major constraint. Only about 800 of Texas’ estimated 80,000 board-certified physicians are registered to recommend medical cannabis. Federal momentum toward cannabis rescheduling could alter that dynamic if more doctors view participation as medically and legally secure.
Why Major Cannabis Companies Are Finally Looking at Texas
Momentum is building on the business side. In December, the Texas Department of Public Safety conditionally approved nine new dispensary licenses, each tied to a specific geographic region.
Applicants include affiliates of Trulieve Cannabis Corp. and Verano Holdings, signaling growing confidence in the Texas medical cannabis program. Their interest reflects expectations that patient growth, infrastructure investment, and regulatory clarity are finally aligning.
Although sales figures remain confidential, the arrival of multistate operators suggests long-term market viability rather than speculative entry.
Infrastructure Investment Signals Confidence in Demand
Existing license holders are also expanding. In December, Texas Original opened a 75,000-square-foot medical cannabis campus near Austin, the largest facility of its kind in the state. Company leadership said the expansion could increase production capacity by 20 times.
The expanded program also allows satellite dispensing locations, enabling faster pickup and broader delivery coverage. Texas Original currently operates 17 pickup locations statewide, with additional sites under development.
Conclusion
Texas is finally building a medical cannabis system that resembles a functional healthcare program rather than a symbolic one. Expanded eligibility, broader product access, and growing business investment suggest the Texas medical cannabis program is entering a new phase.
This article is based on publicly available legislative records, court filings, industry reports, and published research as of the publication date. Cannabis laws and regulations change frequently — verify current rules with your state’s regulatory agency.
